News | Magnetic Resonance Imaging (MRI) | August 08, 2018

3T MRI Installed at The London Clinic Through Hospital Roof

Siemens Magnetom Vida 3T MRI lowered by high-rise crane into hospital roof in central London

3T MRI Installed at The London Clinic Through Hospital Roof

Image courtesy of The London Clinic

3T MRI Installed at The London Clinic Through Hospital Roof

Image courtesy of The London Clinic

3T MRI Installed at The London Clinic Through Hospital Roof

Image courtesy of The London Clinic

August 8, 2018 — Patients at The London Clinic, a private hospital and charity, will be the first in the United Kingdom to access the latest Siemens magnetic resonance imaging (MRI) technology in September. A high-rise crane carefully lowered the multi-million pound 3.0T MRI scanner through the hospital’s roof on July 14.

A video of the crane drop is available here.

The London Clinic, based on Harley Street, is the first in the U.K. to install the new Siemens Magnetom Vida 3T MRI scanner. The scanner offers high-quality diagnostic imaging  to patients with cancer, orthopedic, urology and neurology conditions.

A 3.0 Tesla MRI scanner works by generating a magnetic field that is twice the strength of other 1.5 Tesla scanners that are widely available in other hospitals. The image clarity and detail is particularly beneficial for health conditions involving the brain, spine, musculoskeletal system and heart, clearly showing small structures or disease within the body, such as small tumors.

“We are proud that The London Clinic is the first hospital in the UK to offer our consultants and patients access to the new Siemens Magnetom Vida 3T MRI scanner,” said Al Russell, chief executive at The London Clinic.

“Our multi-million pound investment provides more appointments and comfort for patients and is a key part of strategy to support our consultants in accurate diagnosis to deliver the best health outcomes for patients. The crane installation in central London was a spectacle in the skyline and expertly managed by the project team,” he added.

“Our new MRI suite is located in our purpose-built cancer center, the Duchess of Devonshire Wing. The priority when designing the suite was patient comfort, ensuring we set the stage for our patients to feel at ease during their stay with us,” said Sophie Auld, interim director of clinical services at The London Clinic.

“This 3T MRI technology produces a higher spatial resolution resulting in better visualization of anatomic structures, and subtle abnormalities can more easily be detected in cancer, orthopedics, urology and neurology conditions. Improved imaging allows the early detection of conditions and can reduce the need for unnecessary biopsies. The new 3T MRI offering increases our hospital’s ability to see more patients and develop new services. Appointments are available from Sept. 14,” she added.

As well as growing existing services, the following new services are set to be introduced at The London Clinic thanks to the new Magnetom Vida 3T MRI scanner:

  • Spectroscopy to measure the chemical composition of tissue, and therefore can increase the accuracy of diagnosis in conditions of the brain, prostate or spine;
  • Functional brain imaging to detect minute changes in blood flow and is used to understand how an injured or diseased brain is functioning, or detect early onset Alzheimer’s;
  • Prostate 3.0T MRI to detect small tumors which may otherwise go undetected, and also in detecting tumor reoccurrence for patients with prostate cancer;
  • Radiotherapy MRI planning to detect head, neck, thyroid and female pelvis (gynaecology) tumors; and
  • Interventional biopsies under MRI guidance to remove tissue samples from the breast or prostate for example, for examination under a microscope.

For more information: www.thelondonclinic.co.uk

 

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...